Disparate results in studies of adalimumab in the treatment of hidradenitis suppurativa: comment on the article by Amano et al

Int J Dermatol. 2013 Mar;52(3):380-1. doi: 10.1111/j.1365-4632.2011.04949.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Antibodies, Monoclonal / administration & dosage*
  • Female
  • Hidradenitis Suppurativa / drug therapy*
  • Humans
  • Male

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal